The Burden of Hepatitis B Virus Infection in Kenya: A Systematic Review and Meta-analysis

Overview

Journal Front Public Health

Specialty Public Health

Date 2023 Feb 13

PMID 36778557

Authors

Grace Naswa Makokha

Peiyi Zhang

C Nelson Hayes

Elijah Songok

Kazuaki Chayama

Affiliations

Soon will be listed here.

Abstract

Background: Chronic Hepatitis B virus (HBV) infection causes liver cirrhosis and cancer and is a major public health concern in Kenya. However, so far no systematic review and meta-analysis has been conducted to estimate the burden of disease in the country. A better understanding of HBV infection prevalence will help the government implement efficient strategies at eliminating the disease. This systematic review and meta-analysis was therefore conducted to summarize and update the available information on the burden of HBV in Kenya.

Method: We systematically searched PubMed, Science Direct, Web of Science, Scopus, African Journals OnLine, and Google Scholar databases to retrieve primary studies conducted between January 1990 and June 2021 that assessed the prevalence of HBV infection in Kenya based on measurement of the Hepatitis B Surface Antigen (HBsAg). Meta-analysis was performed using the random effects model where HBsAg prevalence was estimated at a 95% confidence interval (CI) after simple pooling analysis. Potential sources of heterogeneity were also investigated.

Results: Fifty studies were included in the meta-analysis with a sample size of 108448. The overall pooled prevalence estimate of HBV in Kenya was 7.8% (95% CI: 5.8-10.1). Subgroup analysis revealed the highest prevalence among patients presenting with jaundice at 41.7% (95% CI: 13.5-73.3) whereas blood donors had the lowest prevalence at 4.1% (95% CI: 2.4-6.3). Prevalence in Human Immunodeficiency Virus (HIV)-infected individuals was 8.2% (95% CI: 5.8-11.0). An estimate of the total variation between studies revealed substantial heterogeneity (I = 99%) which could be explained by the study type, the risk status of individuals, and the region of study.

Conclusion: We present the first systematic review and meta-analysis of the prevalence of HBV in Kenya. Our results show that the burden of HBV in Kenya is still enormous. This calls for an urgent need to implement public health intervention measures and strategic policies that will bring the disease under control and lead to final elimination.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=264859, identifier: CRD42021264859.

Citing Articles

SEROPREVALENCE OF HBsAg, HCV AND HIV AND ASSOCIATED RISK FACTORS IN A CORRECTIONAL FACILITY IN SOUTHERN NIGERIA: A CROSS-SECTIONAL STUDY.

Egbi O, Oyedepo D, Edeki I, Aladeh D, Ujah T, Okpiri J Ann Ib Postgrad Med. 2025; 22(2):54-60.

PMID: 40007706 PMC: 11848359.

Mathematical modeling and simulation of hepatitis B transmission dynamics with passive immunity and control strategies.

Mirgichan J, Ngari C, Karanja S, Muriungi R Heliyon. 2025; 11(2):e41744.

PMID: 39897899 PMC: 11786659. DOI: 10.1016/j.heliyon.2025.e41744.

Infection with soil-transmitted helminths and their impact on coinfections.

Schlosser-Brandenburg J, Midha A, Mugo R, Ndombi E, Gachara G, Njomo D Front Parasitol. 2025; 2():1197956.

PMID: 39816832 PMC: 11731630. DOI: 10.3389/fpara.2023.1197956.

Real-world experience with nucleos(t)ide analogue therapy and patient survival rates in chronic viral hepatitis B treatment centers in Eritrea.

Solomon M, Ghebremeskel G, Achila O, Mebrahtu A, Hamida M, Mesfin A Sci Rep. 2025; 15(1):824.

PMID: 39755688 PMC: 11700113. DOI: 10.1038/s41598-024-79600-y.

Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018.

Ondondo R, Muthusi J, Oramisi V, Kimani D, Ochwoto M, Young P PLoS One. 2024; 19(11):e0310923.

PMID: 39541401 PMC: 11563396. DOI: 10.1371/journal.pone.0310923.

References

Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi L, Sagnelli E . Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015; 21(42):11941-53. PMC: 4641116. DOI: 10.3748/wjg.v21.i42.11941. View

Otedo A, McLigeyo S, Okoth F, Kayima J . Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J. 2003; 93(5):380-4. View

Macharia P, Giorgi E, Thuranira P, Joseph N, Sartorius B, Snow R . Sub national variation and inequalities in under-five mortality in Kenya since 1965. BMC Public Health. 2019; 19(1):146. PMC: 6360661. DOI: 10.1186/s12889-019-6474-1. View

Petruzziello A . Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. Open Virol J. 2018; 12:26-32. PMC: 5842386. DOI: 10.2174/1874357901812010026. View

Quadri N, Shah S, Rodin H, Debes J . Promoting Hepatitis B Awareness: Evaluating an Educational Approach through Health Care Workers in Tanzania. Ann Glob Health. 2021; 87(1):22. PMC: 7908926. DOI: 10.5334/aogh.3045. View

Sonderup M, Spearman C . Global Disparities in Hepatitis B Elimination-A Focus on Africa. Viruses. 2022; 14(1). PMC: 8777803. DOI: 10.3390/v14010082. View

Spearman C, Afihene M, Ally R, Apica B, Awuku Y, Cunha L . Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017; 2(12):900-909. DOI: 10.1016/S2468-1253(17)30295-9. View

Arbuthnot P, Kew M . Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol. 2001; 82(2):77-100. PMC: 2517704. DOI: 10.1111/j.1365-2613.2001.iep0082-0077-x. View

Olakunde B, Adeyinka D, Olakunde O, Uthman O, Bada F, Nartey Y . A systematic review and meta-analysis of the prevalence of hepatitis B virus infection among pregnant women in Nigeria. PLoS One. 2021; 16(10):e0259218. PMC: 8555786. DOI: 10.1371/journal.pone.0259218. View

10.

Mwangi J . Viral markers in a blood donor population. East Afr Med J. 1999; 76(1):35-7. View

11.

Schweitzer A, Horn J, Mikolajczyk R, Krause G, Ott J . Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003):1546-55. DOI: 10.1016/S0140-6736(15)61412-X. View

12.

Njeru D, Mwanda W, Kitonyi G, Njagi E . Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi. East Afr Med J. 2011; 86(12 Suppl):S58-61. DOI: 10.4314/eamj.v86i12.62903. View

13.

Greer A, Ou S, Wilson E, Piwowar-Manning E, Forman M, McCauley M . Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052. J Acquir Immune Defic Syndr. 2017; 76(4):388-393. PMC: 5659928. DOI: 10.1097/QAI.0000000000001511. View

14.

Wahome E, Ngetsa C, Mwambi J, Gelderblom H, Manyonyi G, Micheni M . Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya. Open Forum Infect Dis. 2017; 4(1):ofw253. PMC: 5499746. DOI: 10.1093/ofid/ofw253. View

15.

Irungu E, Mugo N, Ngure K, Njuguna R, Celum C, Farquhar C . Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya. J Infect Dis. 2012; 207(3):402-10. PMC: 3537443. DOI: 10.1093/infdis/jis695. View

16.

Ogutu E, Amayo E, Okoth F, Lule G . The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS). East Afr Med J. 1990; 67(5):355-8. View

17.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

18.

Aluora P, Muturi M, Gachara G . Seroprevalence and genotypic characterization of HBV among low risk voluntary blood donors in Nairobi, Kenya. Virol J. 2020; 17(1):176. PMC: 7666503. DOI: 10.1186/s12985-020-01447-2. View

19.

Ngaira J, Kimotho J, Mirigi I, Osman S, Nganga Z, Lwembe R . Prevalence, awareness and risk factors associated with Hepatitis B infection among pregnant women attending the antenatal clinic at Mbagathi District Hospital in Nairobi, Kenya. Pan Afr Med J. 2017; 24:315. PMC: 5267875. DOI: 10.11604/pamj.2016.24.315.9255. View

20.

Jepkemei K, Ochwoto M, Swidinsky K, Day J, Gebrebrhan H, McKinnon L . Characterization of occult hepatitis B in high-risk populations in Kenya. PLoS One. 2020; 15(5):e0233727. PMC: 7255601. DOI: 10.1371/journal.pone.0233727. View